The duration of ERK 1/2 activity determines the activation of c-Fos and Fra-1 and the composition and quantitative transcriptional output of AP-1

被引:54
作者
Chalmers, Claire J. [1 ]
Gilley, Rebecca [1 ]
March, Helen N. [1 ]
Balmanno, Kathryn [1 ]
Cook, Simon J. [1 ]
机构
[1] Babraham Inst, Mol Signalling Lab, Cambridge CB2 4AT, England
基金
英国生物技术与生命科学研究理事会;
关键词
AP-1; ERK1/2; c-Fos; Fra-1; thrombin;
D O I
10.1016/j.cellsig.2006.09.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The duration of ERK 1/2 activation influences the nature of the biological response to agonist. Members of the AP-1 transcription factor family are well known targets of the ERK1/2 pathway and are expressed in a temporally coordinated fashion during cell cycle re-entry. In CC139 fibroblasts, sustained ERK1/2 activation is required for the expression of Fra-1, Fra-2, c-Jun and JunB, whereas expression of c-Fos is still strongly induced even in response to transient ERK activation. However, the significance of this pattern of expression for AP-1 activity has not been addressed. Here we show that growth factor stimulated activation of the C-terminal c-Fos transactivation domain (TAD) serves as a sensor for ERK1/2 signal duration whereas the c-JunTAD is not responsive to growth factors. In addition, sustained ERK1/2 activation determines the duration of increases in AP-1 DNA binding complexes as well as their qualitative make up. Finally, this is reflected in both the duration and quantitative transcriptional output of stably integrated AP-1 reporter constructs, indicating that AP-1 activity is finely tuned to ERK1/2 signal duration. These results provide new insights into the importance of ERK 1/2 signal duration in the regulation of AP-1 and provide an explanation for how differences in signal duration can lead to both quantitative and qualitative changes in gene expression. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:695 / 704
页数:10
相关论文
共 42 条
[1]   AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene [J].
Ameyar-Zazoua, M ;
Wisniewska, MB ;
Bakiri, L ;
Wagner, EF ;
Yaniv, M ;
Weitzman, JB .
ONCOGENE, 2005, 24 (14) :2298-2306
[2]   Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression [J].
Bakiri, L ;
Lallemand, D ;
Bossy-Wetzel, E ;
Yaniv, M .
EMBO JOURNAL, 2000, 19 (09) :2056-2068
[3]   Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells [J].
Balmanno, K ;
Cook, SJ .
ONCOGENE, 1999, 18 (20) :3085-3097
[4]   C3 toxin activates the stress signaling pathways, JNK and p38, but antagonizes the activation of AP-1 in rat-1 cells [J].
Beltman, J ;
Erickson, JR ;
Martin, GA ;
Lyons, JF ;
Cook, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (06) :3772-3780
[5]  
BERGERS G, 1995, MOL CELL BIOL, V15, P3748
[6]   Fos family members induce cell cycle entry by activating cyclin D1 [J].
Brown, JR ;
Nigh, E ;
Lee, RJ ;
Ye, H ;
Thompson, MA ;
Saudou, F ;
Pestell, RG ;
Greenberg, ME .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (09) :5609-5619
[7]   Accumulation of fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization [J].
Casalino, L ;
De Cesare, D ;
Verde, P .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (12) :4401-4415
[8]   Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1 [J].
Chalmers, CJ ;
Balmanno, K ;
Hadfield, K ;
Ley, R ;
Cook, SJ .
BIOCHEMICAL JOURNAL, 2003, 375 :99-109
[9]  
Chen RH, 1996, ONCOGENE, V12, P1493
[10]  
Cook SJ, 1999, MOL CELL BIOL, V19, P330